title: Anti-αβ-T-cell receptor antibodies in the setting of laryngeal transplantation.
abstract: Inhibiting T-cell activation is critically important to the induction of transplantation tolerance. Monoclonal antibodies directed against the αβ-T-cell receptor have been shown to cause selective immunodepletion of this T-cell population and can provide long-term allograft acceptance. This article discusses the role of this promising immunosuppressive agent in scientific research and clinical utilization. Specifically, the article focuses on its efficacy and mechanism of tolerance induction in solid tissue and composite tissue allograft transplantation with a particular focus on laryngeal transplantation.
authors.affiliation: New York Head & Neck Institute, NY, NY, USA.
authors.forename: Marshall
authors.initials: M
authors.lastname: Strome
authors.forename: David G
authors.initials: DG
authors.lastname: Lott
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007830:Larynx / Q000637:transplantation*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D051381:Rats; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology*; D023001:Transplantation Tolerance; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D016693:Receptors, Antigen, T-Cell, alpha-beta